Oxford Global Conferences, London
18-19 April 2016
Oxford Global is proud to announce the 3rd Annual Peptides Congress, brining together over 400 senior-level biologics experts from pharmaceutical and biotech companies as well as academic institutions.
The peptides market represents a rapidly expanding area of pharmaceutical research. In addition to this, it has been recently highlighted that the global peptide therapeutics market will reach $23.7 billion by 2020. Our conference focuses on pioneering peptide research results and peptide therapeutics.
The agenda will run over two streams:
• Advances In Peptides Research And Technologies
• Case Studies In Peptide Therapeutics
On day one our highly acknowledged speakers will focus on the recent advancements in peptides research and technologies. Presentations will cover important areas such as novel formulation strategies for peptides, improved half-life extension methods and updates in macrocyclic, cell-penetrating and cyclic peptides. Technological advancements in peptide synthesis, screening and modification will also be addressed.
On day two of the conference delegates will have the exclusive opportunity to hear presentations covering peptide therapeutics. Our highly distinguished experts will discuss the recent improvements in peptide drug delivery systems, utilising peptides in the clinic and peptide drug conjugates. Presentations will also extend to the exciting outcomes of therapeutics research as well as peptide drug conjugates.
Confirmed speakers include:
• Abhijit Bhat, Vice President, Chemistry, Ipsen
• ChiChi Huang, Scientific Director, Janssen
• Les Miranda, Director Research, Amgen
The 3rd Annual Peptides Congress forms part of Oxford Global’s highly successful Biologics Conference Series, allowing delegates to join scientific discussions about the current landscape of the biologics industry and overcoming future challenges in order to help the industry going forward.
The event will be co-located with the following events:
• 9th Annual Proteins & Antibodies Congress
• 4th Annual Biosimilars & Biobetters Congress
|
|